Jones Financial Companies
NNVC icon

Jones Financial Companies’s NanoViricides NNVC Stock Holding History

Jones Financial Companies’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.02K Hold
3,000
– – ﹤0.01% 4192
2026
Q1 		$2.72K Hold
3,000
– – ﹤0.01% 4062
2025
Q4 		$3.39K Buy
+3,000
New +$4.21K ﹤0.01% 3659

Other funds holding NNVC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jones Financial Companies's NNVC Position: Q2 2026 in Review

Jones Financial Companies held its NanoViricides (NNVC) position steady in Q2 2026 at 3,000 shares worth $4.02K. The position accounts for ﹤0.01% of the portfolio, ranked #4192.

Jones Financial Companies first reported a position in NNVC in Q4 2025 and has held it in 3 quarters since. 47 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

  • Jones Financial Companies held 3,000 shares of NanoViricides worth $4.02K as of Q2 2026.
  • Jones Financial Companies left its NanoViricides share count unchanged in Q2 2026.
  • NanoViricides made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4192 holding.
  • Jones Financial Companies first reported a position in NanoViricides in Q4 2025 and has held it in 3 quarters since.
  • 47 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.